Form 8-K - Current report:
SEC Accession No. 0001641172-25-008346
Filing Date
2025-05-02
Accepted
2025-05-02 16:11:24
Documents
13
Period of Report
2025-04-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35577
  Complete submission text file 0001641172-25-008346.txt   209104

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pali-20250429.xsd EX-101.SCH 3024
3 XBRL LABEL FILE pali-20250429_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pali-20250429_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 25908641
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)